The global Tumor Biomarker Test Kits Market is estimated to be worth USD 13.1 Billion in 2022 and is projected to reach the value of USD 29.76 Billion in 2030 growing at the CAGR of 10.8% during the forecast period 2023 – 2030.
A biological marker or biomarker is an indicator that measures biological states or conditions. Biomarker testing kits are usually used to detect cancer and also other diseases by looking at genes, proteins, or other substances which can provide information about the disease in different parts of the body and keep track of it during the treatment or after it to help doctors keep track of the disease. Biomarker testing paired with a specific treatment may be called a companion diagnostic test. Biomarker testing is an important part of precision medicine that is an approach to medical care.
Wide prevalence and an increasing number of tumors and cancer in patients across the world, breakthroughs in scientific and technological advancement, and patients opting for non-invasive, efficient, reliable, and cost-effective methods of testing kits have been important factors for the growth of tumor biomarker test kits. Various pharmaceutical companies have been investing in the Research and Development of testing kits which will further be estimated to increase the market of tumor biomarker test kits market during the forecast period.
Global Tumor Biomarker Test Kits Market Drivers:
Growing cases of tumors and a method for their treatment across the world have been fueling the growth of Global Tumor Biomarker Test Kits.
The cases related to tumors and cancers are at an all-time high due to smoking, rising pollution, and poor dietary habits, and are one of the highest reasons for death around the world. Around one-third of the death around due to cancer are related to tobacco usage, alcohol consumption, high body mass index, and lack of physical activity. This is expected to increase the market for Tumor Biomarker Test Kits as people want to detect tumor-related diseases at a very early stage and get treated quickly to decrease the chances of severity.
Increasing cases investments by private companies are also contributing to the growth of the Global Tumor Biomarker Test Kits.
Many Pharmaceutical companies have been investing a lot of capital in research and development of biomarkers test kits to keep advancing and improving the quality of the testing kits as consumers across the world have been opting for a more efficient and cost-effective method of diagnostic and treatment. Various government across the world have been lowering tax rates and subsidies to keep the prices of test kits especially as important as tumor test kits lower so that it is available to a wider range of people. Factors like this are expected to grow the market of Global Tumor Biomarker Test Kits significantly during the forecast period.
Global Tumor Biomarker Test Kits Market Challenges:
Even with the increasing cases of tumors and cancer around the world, breakthroughs in scientific treatments, and the advancement in biomarker testing kits, there has been a lack of reimbursement policies for biomarker tests in developed countries, the high cost of diagnosis and treatment for disease related to tumors in the developing countries is limiting the market as patients are increasingly preferring low-cost detection tests and the number of patients undergoing biomarker treatment is decreasing which can be the major reason that can hamper the growth of Global Tumor Biomarker Test Kits during the forecast period.
Global Tumor Biomarker Test Kits Market Opportunities:
The rapid expansion of biomarker testing services stems from their potential to enhance the development of new and creative medications and biologic products crucial for addressing the ongoing pandemic. These services encompass a range of disease-specific biomarkers that offer quicker and more precise disease identification. This subsequently trims down the timeline for clinical trials in medical research and expedites the overall drug development procedure. Notably, these testing services find extensive application in advancing cancer treatment solutions by detecting alterations in the genetic composition of cells. The anticipated benefits of biomarker testing kits are expected to support the market’s growth during the forecast period.
COVID-19 Impact on Global Tumor Biomarker Test Kits Market:
The pandemic initially hampered research and developmental activities owing to lockdowns and disruption in supply chain management but it opened a new avenue for the market. As people grew more careful about their health and demanded a more efficient, cost-effective, reliable, and quick method of diagnosis and treatment which fuelled the growth of the Tumor Biomarker Test Kits market. With the lifting of lockdowns and life coming back to normal, the research and investments in this sector have again ramped up with a higher growth rate than before. Hence, the overall effect of the COVID-19 pandemic on the Global Tumor Biomarker Test Kits Market was moderate and the market is estimated to show significant growth in the coming future.
Global Tumor Biomarker Test Kits Market Recent Developments:
In June 2022, Nonagen Bioscience revealed that its Oncuria immunoassay for bladder cancer has received a CE marking. This pioneering Oncuria test stands out as a multiplex urine analysis capable of quantitatively identifying 10 specific biomarkers linked to the existence of bladder cancer.
In February 2022, the OncoDEEP Solid Tumor Biomarker Test Kit has been launched by OncoDNA. This kit, which incorporates enrichment and library preparation solutions from Twist Bioscience, offers laboratories a comprehensive and dependable option for conducting in-depth next-generation sequencing (NGS) analysis on tumor samples.
In March 2023, Prestige Biopharma is currently engaged in developing a diagnostic kit specifically crafted for the detection of Pancreatic Adenocarcinoma Upregulated Factor (PAUF). This exceptional biomarker is highly specific to tumors and is found to be overexpressed in around 80% of pancreatic cancer instances, showing a strong connection with early advancement and the spread of the disease. During the application of Receiver Operating Characteristic (ROC) analysis, a method employed to assess the efficacy of a biomarker, PAUF exhibited a significant sensitivity rate of more than 86% when detecting pancreatic cancer.
TUMOR BIOMARKER TEST KITS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
10.8% |
|
By Tumor Detection, Type, Application, Technology, and Region |
|
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Prestige Biopharma, Bio Agilytix Labs, Euro fins Scientific, SGS SA, OncoDEEP, ICON Plc, IQVIA, Syneos Health, Nonagen Bioscience, Intertek Group |
Lung
Breast
Ovarian
Liver
Stomach
Prostate
Others
Cancer and tumor in the lungs is the second leading reason for death in the world accounting for more than 13% of all new cases diagnosed in 2022. This has been caused due to increasing smoking of tobacco, exposure to asbestos, certain metals, organic compound, radiation, air pollution, and various other reasons. Diagnostic test kits for lungs have dominated for this segment and are estimated to rise resulting in market expansion in the coming years. Biomarker test kits for breasts have also shown considerable growth for the year 2022 and are estimated to increase during the forecast period.
Protein
Genetic
Others
The global market was dominated by the Protein segment in 2022 and the segment is poised to maintain its position in the global biomarker market during the forecast period. The research in tumor treatments has been using protein biomarkers which have led to an increase in the market of this segment. Protein biomarkers are one of the most commonly used and accurate measuring biomarkers in the market that can be used to detect various kinds of tumors.
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
The pharmaceutical company’s segment dominated the market and held the highest share of around 45% in 2022. There has also been a rising interest among pharmaceutical companies to develop targeted therapies for tumors Research institutes and diagnostic laboratories have also been significantly contributing to the growth of the market with increased funding of clinical research. Pharmaceutical companies are estimated to maintain their position as the most dominant segment in the market while research institutes and diagnostic laboratories are estimated to show considerable growth in the market during the forecast period.
Immunoassay
Imaging
Omics
Others
The Omics segment has dominated the market share in 2022. Due to its high efficiency in the early diagnosis of tumors, patients prefer to use the Omics technology. Further research and development and investment in this technology are estimated to grow the market of this biomarker technology. There has also been a growing demand for Immunoassay biomarker technology which is estimated to rise significantly in the coming future as a growing number of clinical trials and drug discovery activities are using immunoassay biomarker technology.
North America
Europe
Asia-Pacific
South America
Middle East & Africa
North America held the highest market share of more than 45% in 2022. The market in this region is bolstered by several factors, including the presence of prominent market players offering biomarker testing services, an uptick in the prevalence of diseases prompting a surge in laboratory diagnostic testing, the existence of sophisticated healthcare infrastructure, and a rising level of research and development investment from public organizations within the region. Asia-Pacific region is also estimated to witness one of the fastest growth during the forecast period.
Global Tumor Biomarker Test Kits Market Key Players:
Prestige Biopharma
Bio Agilytix Labs
Euro fins Scientific
SGS SA
OncoDEEP
ICON Plc
IQVIA
Syneos Health
Nonagen Bioscience
Intertek Group
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The global Tumor Biomarker Test Kits Market is estimated to be worth USD 13.1 Billion in 2022 and is projected to reach the value of USD 29.8 Billion in 2030 growing at the CAGR of 10.8% during the forecast period 2023 – 2030
Rise in several tumors across the world and increasing research and developmental activities coupled with investment by companies.
Based on Type, the Global Tumor Biomarker Test Kits are segmented into Protein, Genetic, and Others.
The United States is the most dominating country in the region of North America for the Global Tumor Biomarker Test Kits Market.
Prestige Biopharma, Bio Agilytix Labs, Euro fins Scientific, SGS SA, OncoDEEP, ICON Plc, IQVIA, Syneos Health, Nonagen Bioscience, Intertek Group
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
